Sumitomo Mitsui Trust Holdings Inc. increased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 5.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 243,935 shares of the company’s stock after purchasing an additional 12,382 shares during the period. Sumitomo Mitsui Trust Holdings Inc.’s holdings in Neurocrine Biosciences were worth $32,141,000 […]
Neurocrine Biosciences (NASDAQ:NBIX) Rating Reiterated by Wedbush themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Assenagon Asset Management S.A. lowered its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 46.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 315,560 shares of the company’s stock after selling 268,979 shares during the quarter. Assenagon Asset Management […]
Assenagon Asset Management S.A. Lowers Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
WINTON GROUP Ltd grew its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 68.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,272 shares of the company’s stock after acquiring an additional 1,738 shares during the period. WINTON GROUP Ltd’s […]